Jan, Y. J. A., Sweeney, K., Elliott, A., Hsieh, R. W., Kuang, C., Habibzadeh, P., Rahman, S., Shroff, R., Lenz, H., Goel, S., Singhi, A. D., Gorantla, V. C., Rhee, J. C., Zhang, J. Y., Saeed, A., Hsu, D. (2026). Survival outcomes of human epidermal growth factor receptor 2 (HER2)–amplified and HER2-mutated left-sided colorectal cancer (CRC) patients treated with anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3543